(Accelerated) p
artial breast irradiation –
standard care
- Targit trial en polgar trial zijn
gepubliceerd
• Low local recurrence risk in selected low-risk patients
• Toxicity and cosmetic outcome: In
PBI
similar or less toxicity
• Ongoing phase III trials (i.e. NSABP B-39, RAPID)